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Original Article

Pancreatic Operations in Children, an Institutional Experience and Review of
Literature
Varun Puri, Lisa Martin, Shawn D St Peter, Georger W Holcomb III, Daniel J Ostlie,
Department of Surgery Children’s Mercy Hospital and Clinics, Kansas City, Missouri

ABSTRACT
Pancreatic operations are not commonly performed in the pediatric age group. Tumors, chronic pancreatitis, trauma and
hyperinsulinemic hypoglycemia are the main diseases leading to pancreatic resections in children. Excluding patients with
acute pancreatitis and pseudocysts, over the last 5 years we have performed operations in 11 children for pancreaticoduodenal
pathology. The diagnoses encountered were tumors or tumor like conditions (four), angiodysplasia (one), chronic pancreatitis
(one), traumatic pancreatic transection (three), traumatic pseudocyst, and neonatal hyperinsulinemic hypoglycemia (one).
Operations performed were: pancreaticoduodenectomy (PD) in three patients, subtotal or distal pancreatectomy in six
patients, distal pancreaticojejunostomy with oversewing of the proximal pancreatic duct in one patient, and total
pancreatectomy, pancreatic cystgastrostomy, and pancreatic biopsies with biliary drainage in a single patient each. There was
no operative mortality and one patient developed a pancreatic leak that resolved with drainage. Other morbidity included
exocrine (n=3) and endocrine (n=2) insufficiency, intraoperative bile duct injury managed by choledochoduodenostomy
(n=1), and delayed gastric emptying (n=1). Adjuvant treatment was needed in two patients for malignant tumors. Overall
the children tolerated these pancreatic operations quite well.

INTRODUCTION

T

he pancreas is not a common site of surgical
pathology in children. In children, pancreatic
resections are usually performed for neoplasia,
chronic pancreatitis (CP), trauma, or persistent
hyperinsulinemic hypoglycemia.1,2,3,4,5 The main
pancreatic tumors in children are pancreatoblastomas,
papillary cystic tumors and malignant endocrine
tumors of the pancreas.6 These are usually managed
surgically and evidence for the role of adjuvant
therapy is nearly entirely anecdotal. Pancreatic
trauma may need surgery for duct disruption or
pseudocysts. CP may necessitate a pancreatic ductal
drainage procedure or pancreatic resection for
intractable pain, biliary complications or when
pancreatitis is indistinguishable from a neoplasm.

Children with hyperinsulinemic hypoglycemia who
fail medical management require pancreatic resection.
Overall, children tolerate pancreatic operations fairly
well.

PATIENTS AND METHODS
After obtaining IRB approval a retrospective review
was
performed
of
all
patients
with
pancreaticoduodenal pathology requiring pancreatic
operations that were less than 18 years of age and
were cared for at The Children’s Mercy Hospital,
Kansas City, MO between 1998 and 2004. Patients
with pancreatic pseudocysts secondary to acute
pancreatitis were excluded. Eleven patients were
identified and reviewed for clinical presentation,
operative intervention and outcome with follow-up.
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RESULTS
Eleven patients ranging in age from 1 week to 17
years were identified. There were 6 boys and 5 girls.
The resections/operations were performed for mass
lesions in 4 cases.
CASES 1-4
A 9-year old presented with obstructive jaundice and
abdominal pain of brief duration. An abdominal CT
scan
revealed
a
mass
lesion
of
the
duodenum/pancreatic head (Figure 1). Endoscopic
biopsies revealed adenocarcinoma.
Preoperative
biliary stenting followed by pylorus-sparing
pancreaticoduodenectomy (PSPD) was performed.
Pathology
revealed
a
poorly
differentiated
adenocarcinoma with pancreatic and duodenal
involvement. Resection margins were negative for
malignancy and one of 7 lymph nodes was positive
for metastatic adenocarcinoma. Postoperatively there
was no evidence of endocrine or exocrine deficiency.
Adjuvant therapy with 5 FU and leucovorin was
employed and the child remains disease free at 40
months of follow-up.
A 1-week old infant presented with conjugated
hyperbilirubinemia. Diagnostic evaluation included
an abdominal ultrasound and CT scan that revealed a
mass lesion in the head of the pancreas. Pathology
after
exploratory
laparotomy
and
pancreaticoduodenectomy (PD) revealed infantile
myofibromatosis with no evidence of disease in
lymph nodes. Pancreatic exocrine deficiency requiring
enzymatic replacement developed post-operatively.
No adjuvant therapy was required and the child is
disease free at 5 years of follow-up.
A 13 year-old was found to have a mass in the region
the region of the body and tail of the pancreas on a CT
scan performed for abdominal pain. Exploratory
laparotomy was undertaken and a distal
pancreatectomy was performed for resection of the
mass. Final pathologic analysis revealed a solid and
cystic papillary epithelial neoplasm with an involved
margin of resection. Repeat resection of the margin of
the remaining pancreatic tissue along with
splenectomy was subsequently performed. Transient
hyperglycemia developed after this resection. There
was no evidence of disease outside the pancreas and
the patient is disease free at 5 years of follow-up.
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An 8-year old presented with progressive obstructive
jaundice and chronic vague abdominal pain with an
abdominal ultrasound and CT scan localizing a mass
lesion in the head of the pancreas. There was no
associated exocrine deficiency or diabetes.
At
exploratory laparotomy, multiple transduodenal
pancreatic biopsies were performed and revealed only
inflammatory changes of chronic pancreatitis. A
Roux-en-y hapaticojejunostomy was performed to
relieve the biliary obstruction, and the child recovered
uneventfully. No adjuvant treatment was needed and
the child is doing well at 3 years follow-up with no
exocrine or endocrine deficiency.
CASE 5
A 9-year old presented with recurrent upper
gastrointestinal
bleeds
requiring
multiple
transfusions.
An
esophagogastroduodenoscopy
revealed a vascular malformation of the duodenum
and remaining workup was negative. Of note, the
patient had undergone a Ladd’s procedure for
malrotation, and repair of Tetralogy of Fallot as an
infant. To accomplish adequate resection, a PD was
performed. Postoperatively, a pancreatic leak and
lesser sac abscess developed. Operative drainage was
performed and the leak resolved. Histology revealed
angiodysplasia of the duodenum and non-specific
inflammation. The patient has since developed similar
lesions in the stomach and proximal small bowel and
has required transfusions and endoscopic treatment
for the same. Pancreatic exocrine and endocrine
deficiency has also developed and enzymatic
supplementation and insulin are required at 5 years of
follow-up.
CASE 6
A17-year old presented with long standing, crippling
chronic abdominal pain due to chronic pancreatitis
with exocrine and endocrine insufficiency. Distal
pancreatectomy was performed in an attempt to
relieve pain however, was unsuccessful. Five months
later
the
patient
underwent
completion
pancreatectomy. The abdominal pain was relieved
after the second operation and pancreatic exocrine
and endocrine replacement therapy was continued.
Unfortunately the patient died due to unrelated
causes 2 years postoperatively.
CASE 7-10
A 9-year old sustained abdominal trauma while
riding bicycle and being struck by an automobile, and
23
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a 6-year old presented with abdominal pain after
abdominal trauma at play. In both cases, clinical
examination revealed epigastric tenderness and
abdominal CT scans showed evidence of complete
transection of the neck of the pancreas. In both
scenarios a spleen preserving distal pancreatectomy
was performed within one day of the initial trauma,
and their recovery was uneventfully. Neither has
developed
pancreatic
insufficiency
in
the
postoperative period and they are doing well at 4 and
5 years post injury.
A 14-year old presented to the emergency after being
a lap belt only restrained passenger involved in a
motor vehicle accident. Abdominal CT revealed a
pancreatic transaction and exploration of the lesser
sac revealed a complete pancreatic transection of the
neck of the pancreas. The proximal pancreatic duct
was ligated and enteric drainage of the distal stump
was accomplished via a Roux-en-Y jejunal limb. The
postoperative course was uneventful and the patient
remains symptom free at 2 years follow-up.
A 16-year old was transferred to our institution 3 days
after sustaining abdominal trauma in an MVA.
Physical exam findings on admission included
peritoneal irritation and fever. A CT scan of the
abdomen was obtained and was consistent with
pancreatic transection at the level of the body (Figure
2 A-D). Exploratory laparotomy and exploration of
the lesser sac was performed and no evidence for
pancreatic disruption was identified. External
drainage was accomplished via JP drains. These
drains were subsequently removed at 2 weeks
postoperatively when there had been return of bowel
function and appropriate volumes from the drains.
Laboratory evaluation for lipase levels of the drain
fluid was similar to serum lipase. Two months later a
pancreatic pseudocyst developed (Figure 3) that
subsequently
required
cystgastrostomy
for
obstructive symptoms. The patient remains symptom
free while on a low fat diet, however does have
recurrent abdominal pain when he eats foods high in
fat.
CASE 11

diagnosis
of
persistent
hyperinsulinemic
hypoglycemia was confirmed and a distal (95%)
pancreatectomy was performed. Intraoperatively, the
distal common bile duct was partially transected near
its insertion into the duodenum. This was detected
immediately and a choledochoduodenostomy was
performed. Subsequently the infant had an
uncomplicated postoperative course and pathology
revealed presence of focal nesidioblastosis in the
pancreas. The patient continues to do well and has not
developed diabetes at 4 years of follow up. No
adjuvant therapy has been needed. Neurological
development is appropriate.
Our patients ranged from 1 week to 17 years of age.
Table 1 highlights the clinical data of these patients.
These 11 children underwent a multitude of
pancreatic
operations
including:
pancreaticoduodenectomy – three (one of them
pylorus sparing), subtotal /distal pancreatectomy–
six, total pancreatectomy– one, ligation of proximal
pancreatic duct and enteric drainage of the distal duct
for traumatic transection- one, cystgastrostomy- one,
and pancreatic biopsies with biliary drainage– one.
Postoperative ileus occurred in all patients (as
expected) and mean duration of bowel rest with
nasogastric drainage was 5.3 days. Four patients
required intraoperative blood transfusions, and there
was one bile duct injury that was recognized
intraoperatively and managed via choledochoduodenostomy (case 11). This injury was felt to be due
to an inappropriately distal insertion of the common
bile duct at the junction of the second and third
portions of the duodenum. A single patient developed
a pancreatic leak leading to an abscess requiring
surgical drainage (case 5). One patient had
postoperative delayed gastric emptying after a total
pancreatectomy (case 6), however she also suffered
from long-standing diabetes, which may have
contributed to the problem. Postoperative exocrine
deficiency was seen in 3 patients and 2 patients
developed endocrine deficiency (one was transient).
None of our patients developed a pancreatic fistula
and there was no operative mortality. Two of the 3
patients with tumors required adjuvant therapy.

A 3-week old neonate was seen for intractable
hypoglycemia despite aggressive medical therapy. A
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Fig 1. CT scan of the abdomen. The black outline
surrounds the large tumor involving the pancreatic. The
white arrow identifies the obstructed and enlarged
common bile duct.

Fig 2. Figures A-D show progressive CT cuts through
the body of the pancreas. The arrows identify the
location of the suspected pancreatic transaction.

within the mass of the gland from non-pancreatic cell
types adjacent to it and involving the pancreas
secondarily. These may be rhabdomyosarcoma,8
neuroectodermal tumors,1 lymphoma,9 teratoma10 and
(as in our series) duodenal carcinoma and infantile
myofibromatosis.

Fig 3. A CT scan of the abdomen at the level of the
pancreas and lesser sac. The arrow points out the large
pancreatic pseudocyst.

DISCUSSION
Surgical disorders of the pancreas are distinctly
uncommon in infancy and childhood.2,7 Most
pancreatic operations performed in children are due
to tumors arising from the pancreas or surrounding
tissue or pancreatic trauma.
Pediatric pancreatic tumors arise from exocrine or
endocrine tissue and include ductal adenocarcinoma,
acinar cell carcinoma, pancreatoblastoma, solid
pseudopapillary tumor and endocrine neoplasms.
Also, the pancreas may be involved in tumors arising
Vol 3, No 1, Jan., 2007

Pediatric pancreatic tumors often present with
abdominal pain and jaundice, which is in
contradistinction from the adult population where
these findings are uncommon.1 This likely reflects the
fact that tumors are more evenly distributed along the
length of the gland in children and ductal
adenocarcinoma, the most common pancreatic
neoplasm causing jaundice in adults, is extremely rare
in children.
Ductal adenocarcinoma of the pancreas has been
described in the past, however, Shorter et al,1 have
questioned the diagnosis in the pediatric population.
Our patient (case 1), with ductal adenocarcinoma had
mucinous and papillary differentiation features that
are rarely encountered in ductal adenocarcinoma.
Hence, we agree that “classic” ductal adenocarcinoma
of the pancreas in the pediatric setting is likely to be
an extremely rare tumor.
Pancreatoblastomas are the most common pancreatic
tumors seen in childhood.11 These tumors tend to be
bulky, solitary and can occur in any region of the
pancreas. They contain pluripotent cells on histology,6
and their clinical behavior may be very similar to
25
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acinar cell carcinoma.1 Serum alphafetoprotein (AFP)
levels are often elevated at diagnosis and may be used
to follow these tumors. Surgical resection, whenever
feasible is the mainstay of treatment. Chemotherapy
(cisplatin, doxorubicin, cyclophosphamide, and
etoposide) in the adjuvant and neoadjuvant setting
has been used with encouraging results 1,11,12 and
postoperative radiation may have a role for
incompletely resected disease.13
Solid and papillary epithelial neoplasm of the
pancreas is an uncommon low-grade malignant
tumor seen predominantly in young females.1,11,14 It
has been described variously as Frantz’s tumor, solid
pseudopapillary tumor, papillary cystic neoplasm,
solid and papillary neoplasm, and solid and cystic
tumor. Generally, this neoplasm presents as an
abdominal mass.14 Focal necrosis, hemorrhage into
the tumor and calcification occur commonly,1,15 and
serum AFP levels are normal.14 Adequate treatment is
complete resection, however local residual disease
may not preclude long-term survival.1 Estrogen
and/or progesterone receptors may be present on the
tumor cells prompting the use of tamoxifen in its
treatment protocol.1,16 The role of adjuvant therapy, if
any, is not clearly defined.
Acinar carcinoma is an epithelial tumor with evidence
of acinar cell differentiation. Its presentation is usually
nonspecific and jaundice is infrequent. As many as
16% of patients with acinar carcinoma may present
with arthralgias and subcutaneous fat necrosis from
elevated serum lipase levels.17 Effective treatment
requires complete excision of the tumor However,
there is a high recurrence rate even after complete
resection. Results with chemotherapy and radiation
are disappointing.18 Serous cystadenocarcinoma of the
pancreas has not been reported in the pediatric age
group.
As in the adult population, insulinoma is the most
common endocrine tumor of the pancreas and the
majority of them are benign.11 Patients generally
present with symptomatic hypoglycemia and elevated
insulin levels. Tumor resection is the optimal
treatment. Other pancreatic tumors of endocrine
origin that may be seen in children are gastrinomas,
VIPomas, non-functioning islet cell tumors and
mucinous cystic tumors. Johnson and Spitz,11 have
recently reviewed these neoplasms.
We treated one child with a duodenal carcinoma
presenting as a periampullary lesion. These tumors
26

are typically seen in the older age group and present
with obstructive jaundice. Pathologically, these
periampullary tumors arise from the pancreas (62%),
ampulla of Vater (19%), distal common bile duct
(12%), or duodenum (7%).19 PD is the standard of care
providing the best chance for cure. Extended
resections
including
gastrectomy
and/or
retroperitoneal lymph node dissection do not improve
survival.20 Five-year survival rates for patients with
duodenal carcinomas undergoing PD are expected to
be greater than 50%.20 Regardless of age, familial
adenomatous polyposis predisposes to ampullary
neoplasms.21
Infantile myofibromatosis is the most common fibrous
tumor of infancy.22 Previously known as congenital
generalized fibromatosis, it can have solitary or
multiple lesions, which may be visceral or peripheral.
Infants with visceral lesions usually have a benign
course.22 These tumors arise from vascular subintimal
mesenchymal or smooth muscle cells and the cellular
phenotype is that of myofibroblasts.23 Surgical
resection is the treatment of choice for visceral disease
while low dose chemotherapy has been used to
manage the generalized form of the disease.22,23,24
Spontaneous regression of these tumors is quite
common in the peripheral lesions, but extremely rare
in the visceral form of the disease.
We performed a PD for angiodysplasia of the
duodenum
with
recurrent
life-threatening
hemorrhage (case 6). Since, the child has developed
similar malformations in the stomach and proximal
small bowel. The stomach is the most common site of
upper gastrointestinal angiodysplasia, and is
asymptomatic in approximately 50% of patients. 26
They may, however, present with anemia or relatively
large
volume
UGI
bleeds.
Endoscopic
electrocoagulation or injection sclerotherapy is
usually successful in controlling these bleeding
episodes.
Surgery is indicated only when less
invasive therapy is unsuccessful.26,27 Aortic stenosis
and renal impairment are associated with these
lesions.26 Angiodysplasia has also been described in a
duodenal diverticulum,28 as well as in the minor
papilla.29 Our patient developed a pancreatic leak
with an abscess after PD that resolved with drainage.
The pancreaticojejunal anastomosis continues to be
the “Achilles heel” of the Whipple operation with leak
rates ~ 15%.30, 31 The leak can generally be managed
nonoperatively through careful positioning of
intraoperatively
placed
drains.
Pancreaticogastrostomy has been shown to be a safe
Annals of Pediatric Surgery
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and reliable method of reconstruction after PD and
may be associated with a lower leak rate than a
pancreaticojejunostomy.32,33,34 The use of octreotide
remains controversial. It continues to be used
prophylactically for the prevention of pancreatic leaks
after pancreatic resections on the basis of reported
studies, primarily in patients with chronic
pancreatitis.35,36 However, there also exist significant
data that show octreotide to be of no benefit in
preventing pancreatic leaks and postoperative
morbidity after pancreatic resection 37,38 but rather
controls pancreatic volume that may make the leak
more manageable. Based on these data we can make
no recommendation regarding its use for preventing
pancreatic leaks in the pediatric population.
The pancreas and duodenum are the fourth most
common injured organs after kidney, spleen and liver
in children who sustain blunt abdominal trauma.4
Serum amylase and lipase determinations may
support clinical suspicion in the diagnosis of pediatric
pancreatic trauma but are not reliable or cost-effective
as screening tools.39 CT scan remains the main
diagnostic modality used in pediatric blunt
abdominal trauma. Unfortunately, CT scan may not
be conclusive in showing the presence or extent of
pancreatic injury.3,4 Therefore, in otherwise stable
patients with suspected pancreatic ductal injury on
initial CT scan, prompt ERCP is recommended.3
Arkowitz et al 39 have proposed a useful classification
system for pancreatic trauma (Table 2).
A useful algorithm,3 supported by several authors,
has been proposed for management of patients with
ductal disruption. When significant ductal injury is
present, ERCP with stenting should be attempted,
followed by stent removal in 10-12 days.40,41 If
stenting is unsuccessful, distal pancreatectomy is the
most commonly performed operation and has very
good results with a low morbidity.
Pseudocyst formation and pancreatitis are the most
common complications of pancreatic trauma.
Approximately 50% of pseudocysts can be managed
nonoperatively with the remainder requiring some
form of operative drainage.39 A recent study showed
that pancreatic leaks after distal pancreatectomy are
reduced significantly with ligation of the main
pancreatic duct.43
Chronic pancreatitis in childhood is an uncommon
but potentially debilitating disorder. Surgery is an
option in patients with intractable chronic pain who
Vol 3, No 1, Jan., 2007

fail medical management.44 Operations performed
include drainage (lateral pancreaticojejunostomy–
Puestow procedure) or resectional procedures of
varying degree. ERCP has a definite role in the
management of this illness as the findings direct
further
management
strategies.45
Endoscopic
pancreatic drainage and stone removal is a safe and
effective modality of treatment for patients with
chronic calcifying pancreatitis, in whom elevated
intraductal pressures are thought to be the cause of
pain.46 A longitudinal pancreaticojejunostomy is
beneficial for ductal dilatation and associated
pseudocysts or pancreatic ascites. However
mimicking results in the adult population, the
performance of this procedure in the absence of
consistent ductal dilatation gives unsatisfactory
results.47 A resectional procedure may be useful if a
Puestow procedure fails to ameliorate pain,44 with as
many as 75% of patients having a reasonable lifestyle
after pancreatic resection.48,49 Among resectional
procedures, total pancreatectomy has the highest 30day mortality (5%) and morbidity (47%) and should
be avoided. Proximal pancreatectomy will provide
pain relief in ~ 90% patients long-term.49 Duodenal
preserving pancreatic head resection (DPPHR – Beger
procedure) is another surgical option that has been
recently compared against PD and found to be
superior to PD in terms of quality of life, pain relief,
nutritional status and length of hospital stay.50 Two
other surgical options include the Frey procedure
(duodenum-preserving resection of the head of the
pancreas
combined
with
a
longitudinal
pancreaticojejunostomy),51 and duodenum and spleen
sparing total pancreatectomy for end-stage CP.52 The
availability of so many surgical options clearly
implies that none of them are ideal procedures or
provide consistent results. Regarding deterioration of
pancreatic function after pancreatic drainage
procedures or partial pancreatectomy for CP, it is not
an invariable, immediate consequence of the
operation, but rather progression of disease that
contributes to this phenomenon.53
Persistent hyperinsulinemic hypoglycemia is the most
frequent cause of severe, intractable hypoglycemia in
the newborn and infant. Two distinct forms of the
disease have been described since 1989: focal and
diffuse.54 The primary concern in this illness is
neurologic injury secondary to severe hypoglycemia.
To that end, medical management focuses on
maintenance of normoglycemia and consists of
dietetic measures, parenteral nutrition, diazoxide,
27

Ostlie DJ et al

glucagon, and octreotide. Surgery is indicated only
when medical therapy is unsuccessful. Many groups

treat all patients with near-total or subtotal
pancreatectomy, predisposing to a significant

risk of diabetes. Cretolle et al 55 recommend
preoperative differentiation between the focal and
diffuse form of the disease and favor localization of
the focal lesions using pancreatic venous sampling.
This can then direct surgical resection with good

success. Despite aggressive treatment, intermediate
to severe psychomotor retardation occurs in
approximately 20% of these patients with epilepsy
affecting a similar number.56

Table 1.
CASE #

DIAGNOSIS

OPERATION(S)

OUTCOME

1

Adenocarcinoma

PSPD

Alive/DF

2

Myofibromatosis

PD

Alive/DF/Exocrine Def.

3

Papillary Neoplasm

DP

Alive/DF

4

Chronic Pancreatitis

Hapaticojejunostomy

Alive/DF

5

Vascular Malformation

PD

Alive/Exo & Endocrine Def.

6

Chronic Pancreatitis

DP with delayed CP

Died

7

Pancreatic Transection

SPDP

Alive/DF

8

Pancreatic Transection

SPDP

Alive/DF

9

Pancreatic Transection

Distal Pancreaticojejunostomy

Alive/DF

10

Pancreatic Transection

Pancreatic Cystgastrostomy

Alive//DF/Exocrine Def.

11

Nesidioblastosis

95% Pancreatectomy

Alive/DF

PSPD: Pylorus Sparing Pancreaticoduodenostomy; PD: Pancreaticoduodenosotomy; DP: Distal Pancreatectomy; CP:
Completion Pancreatectomy; SPDP: Spleen Preserving Distal Pancreatectomy; DF: Disease Free.

Table 2.
Injury Class

Pancreatic Injury

I

Contusion or laceration without ductal injury

II

Distal transection or parenchymal injury with duct injury

III

Proximal transection or parenchymal injury with proximal duct injury

IV

Combined pancreatic and duodenal injury

CONCLUSION
Pancreatic disorders requiring operations are
uncommon, but well tolerated in the pediatric
population. A multidisciplinary approach, including
28

dietician, endocrinology, gastroenterology, surgery,
and hematology/oncology (for malignant lesions), is
necessary in treating these illnesses at diagnosis and
over the long-term to provide optimal outcomes.
Local complications are the usual cause of morbidity
Annals of Pediatric Surgery
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